Medicare Part D Spending on Insulin Increased 840 Percent Between 2007 and 2017
Medicare Part D spending on insulin increased 840 percent between 2007 and 2017, far outpacing growth in the number of beneficiaries using insulin therapy, according to a new KFF analysis.